Tech Company Financing Transactions
Auspex Pharmaceuticals Funding Round
Auspex Pharmaceuticals secured a $15 million funding round on 1/8/2014. Investors included Oxford Finance.
Transaction Overview
Company Name
Announced On
1/8/2014
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
These financings strengthen the balance sheet as we advance SD-809, our lead program, in Phase 3 clinical development for the treatment of chorea associated with Huntington's disease.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3366 North Torrey Pines Ct. 225
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pratik Shah
Chief Financial Officer
John Schmid
Chief Medical Officer
David Stamler
Chief Operating Officer
Bharatt Chowrira
Chief Operating Officer
Andreas Sommer
Browse more venture capital transactions:
Prev: 1/8/2014: Glooko venture capital transaction
Next: 1/8/2014: Ablative Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs